SSH1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.781830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.982400E-02
Normal-vs-Stage2
2.209600E-01
Normal-vs-Stage3
2.214800E-01
Normal-vs-Stage4
5.153800E-01
Stage1-vs-Stage2
4.938200E-01
Stage1-vs-Stage3
9.444200E-01
Stage1-vs-Stage4
3.606200E-01
Stage2-vs-Stage3
5.308800E-01
Stage2-vs-Stage4
6.805600E-01
Stage3-vs-Stage4
5.348400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.652170E-01
Normal-vs-AfricanAmerican
4.345800E-01
Normal-vs-Asian
1.270570E-01
Caucasian-vs-AfricanAmerican
5.508400E-01
Caucasian-vs-Asian
3.276200E-01
AfricanAmerican-vs-Asian
3.322600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.450410E-01
Normal-vs-Female
2.419800E-01
Male-vs-Female
2.682800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.254400E-02
Normal-vs-Age(41-60Yrs)
4.647000E-01
Normal-vs-Age(61-80Yrs)
1.073560E-01
Normal-vs-Age(81-100Yrs)
1.416420E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.451210E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.664200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.487400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.635800E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.231800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.795800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.804500E-02
Normal-vs-Daily Drinker
6.102100E-02
Normal-vs-Weekly Drinker
3.997600E-01
Normal-vs-Occasional Drinker
1.936410E-01
Normal-vs-Social Drinker
6.765600E-01
Non Drinker-vs-Daily Drinker
8.132600E-01
Non Drinker-vs-Weekly Drinker
7.978400E-02
Non Drinker-vs-Occasional Drinker
1.715190E-01
Non Drinker-vs-Social Drinker
1.328450E-02
Daily Drinker-vs-Weekly Drinker
1.362180E-01
Daily Drinker-vs-Occasional Drinker
2.720800E-01
Daily Drinker-vs-Social Drinker
3.026300E-02
Weekly Drinker-vs-Occasional Drinker
6.036600E-01
Weekly Drinker-vs-Social Drinker
5.332000E-01
Occasional Drinker-vs-Social Drinker
2.266600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.360200E-01
Normal-vs-Grade 2
2.511600E-01
Normal-vs-Grade 3
2.574800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.960000E-02
Grade 1-vs-Grade 3
3.513800E-02
Grade 1-vs-Grade 4
6.360200E-01
Grade 2-vs-Grade 3
5.629200E-01
Grade 2-vs-Grade 4
2.511600E-01
Grade 3-vs-Grade 4
2.574800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.112800E-01
Normal-vs-NonDiabetic
1.437050E-01
Diabetic-vs-NonDiabetic
5.622200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.625200E-01
Normal-vs-NoPancreatitis
1.396770E-01
Pancreatitis-vs-NoPancreatitis
7.806400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.256210E-01
Normal-vs-N1
2.177400E-01
N0-vs-N1
2.233000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.202800E-01
Normal-vs-TP53-NonMutant
1.331030E-01
TP53-Mutant-vs-TP53-NonMutant
4.005400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
